Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neurotransmitter Agents”

49 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 49 results

Large-scale testing (Phase 3)Study completedNCT03396588
What this trial is testing

Non-Opiate Treatment After Prenatal Opiate Exposure to Prevent Postnatal Injury to the Young Brain

Who this might be right for
Neonatal Abstinence Syndrome
Henrietta Bada 120
Testing effectiveness (Phase 2)Study completedNCT02634684
What this trial is testing

Pharmacologically-augmented Cognitive Therapies (PACTs) for Schizophrenia.

Who this might be right for
Schizophrenia
University of California, San Diego 82
Post-approval studies (Phase 4)Study completedNCT01049009
What this trial is testing

The Effect of Nebivolol on Endothelial Dysfunction in African Americans With Hypertension

Who this might be right for
High Blood Pressure
Emory University 91
Not applicableStudy completedNCT03904186
What this trial is testing

Effectiveness of an Integrated Treatment to Address Smoking Cessation and Anxiety/ Depression in People Living With HIV

Who this might be right for
Human Immunodeficiency VirusSmoking CessationSmoking, Cigarette+4 more
Massachusetts General Hospital 131
Testing effectiveness (Phase 2)WithdrawnNCT03610282
What this trial is testing

EEG Study of IV Methylphenidate-Induced Emergence From Propofol Sedation

Who this might be right for
Anesthesia
Massachusetts General Hospital
Testing effectiveness (Phase 2)Study completedNCT05138068
What this trial is testing

Social Anxiety MDMA-Assisted Therapy Investigation

Who this might be right for
Social Anxiety Disorder
Jason B Luoma 90
Early research (Phase 1)Study completedNCT01204723
What this trial is testing

Medications Development for the Treatment of Cannabis Related Disorders

Who this might be right for
Nicotine WithdrawalMarijuana DependenceCannabis Dependence+2 more
University of Virginia 63
Large-scale testing (Phase 3)Looking for participantsNCT06752759
What this trial is testing

Nebulized Ketamine for the Treatment of Major Depressive Disorder in an Inpatient Setting

Who this might be right for
Severe DepressionModerate DepressionKetamine+16 more
Theresa Jacob, PhD, MPH 40
Post-approval studies (Phase 4)Study completedNCT04412096
What this trial is testing

Aqueous Humor Dynamic Components That Determine Intraocular Pressure Variance

Who this might be right for
GlaucomaOHT - Ocular Hypertension
Ohio State University 59
Early research (Phase 1)Study completedNCT03357796
What this trial is testing

Relative Bioavailability (RBA) Study of LY03005 vs Pristiq®

Who this might be right for
Major Depressive Disorder
Luye Pharma Group Ltd. 20
Testing effectiveness (Phase 2)Ended earlyNCT05610969
What this trial is testing

Music vs Midazolam During Preop Nerve Block Placement - Part 2 Study On Anxiolytic Options Before Peripheral Nerve Blocks

Who this might be right for
Peripheral Nerve BlockAnxietyPreoperative Anxiety
University of Pennsylvania 36
Testing effectiveness (Phase 2)Looking for participantsNCT06511908
What this trial is testing

Investigation of the Antidepressant Effects of (2R,6R)-HNK, an Enhancer of Synaptic Glutamate Release, in Treatment-Resistant Depression

Who this might be right for
SuicideDepressive Disorder, Treatment-ResistantKetamine+10 more
National Institute of Mental Health (NIMH) 50
Not applicableLooking for participantsNCT06835595
What this trial is testing

TMS-related Measures as Biomarker of Cognitive Impairment in PD

Who this might be right for
Parkinson Disease
Azienda Provinciale per i Servizi Sanitari, Provincia Autonoma di Trento 52
Not applicableEnded earlyNCT01819675
What this trial is testing

Effect of Repetitive Transcranial Magnetic Stimulation (rTMS) Over the Brain on the Neurotransmitter Binding

Who this might be right for
StrokeHemiplegia
Seoul National University Bundang Hospital 6
Not applicableLooking for participantsNCT06462196
What this trial is testing

Natural History of Depression, Bipolar Disorder and Suicide Risk

Who this might be right for
Behavioral SymptomsSuicideSelf-Injurious Behavior+18 more
National Institute of Mental Health (NIMH) 500
Post-approval studies (Phase 4)Study completedNCT05615948
What this trial is testing

Oral Aspirin + Ketamine as Adjunct to Oral Antidepressant Therapy for Depression

Who this might be right for
Treatment Resistant DepressionMajor Depressive DisorderAnalgesia+10 more
Maimonides Medical Center 15
Post-approval studies (Phase 4)UnknownNCT01710163
What this trial is testing

Potentiation of Quetiapine Treatment With Lithium or Aripiprazole in Bipolar 1 Nonresponders Patients

Who this might be right for
Bipolar I Disorder
University of Sao Paulo 50
Large-scale testing (Phase 3)Study completedNCT01916967
What this trial is testing

An Efficacy and Safety Study of Desloratadine (MK-4117) in Japanese Participants With Chronic Urticaria (MK-4117-201)

Who this might be right for
Urticaria
Organon and Co 239
Very early researchActive Not RecruitingNCT05953038
What this trial is testing

LSD Occupancy of the Serotonin 2A Receptor in the Human Brain

Who this might be right for
Basic Science
Rigshospitalet, Denmark 40
Not applicableNot Yet RecruitingNCT07079046
What this trial is testing

Efficacy of Satisens® in Reducing Emotional Eating

Who this might be right for
Emotional EatingOverweight or ObesityHormonal Changes+5 more
José Enrique de la Rubia Ortí, Ph 84
Load More Results